Caitlin John’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Caitlin John's PCRX Position: Q3 2026 in Review
Caitlin John held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 4,721 shares worth $118K. The position accounts for 0.06% of the portfolio, ranked #247.
Caitlin John first reported a position in PCRX in Q4 2023 and has held it in 10 quarters since. The position peaked at $120K in Q2 2026. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Caitlin John held 4,721 shares of Pacira BioSciences worth $118K as of Q3 2026.
- Caitlin John left its Pacira BioSciences share count unchanged in Q3 2026.
- Pacira BioSciences made up 0.06% of Caitlin John's portfolio in Q3 2026, its #247 holding.
- Caitlin John first reported a position in Pacira BioSciences in Q4 2023 and has held it in 10 quarters since.
- Caitlin John's Pacira BioSciences position peaked at $120K in Q2 2026.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Caitlin John's 13F filing for Q3 2026, filed 16 Nov 2026.